title: Scintigraphic findings of the thyroid in hypothyroid patients with blocking-type TSH-receptor antibodies.
abstract: The present study was designed to analyse the scintigraphic appearance of the thyroid in hypothyroid patients with blocking-type TSH receptor antibodies (TRAbs). Eleven hypothyroid patients with autoimmune thyroiditis positive for TSH binding inhibitor immunoglobulins (TBII) [80% +/- 12 (SD)%; normal < 11%] and for thyroid stimulation-blocking antibodies (TSBAbs) (90% +/- 9%: normal < 32%) were studied. Thyroid scanning was performed using technetium-99m or iodine-123, when the patients were hypothyroid. Analysis of the scan images revealed the presence of localized functioning areas in six patients (group 1), and no visualization of the thyroid in the remaining five patients (group 2). Patients in group 1 showed significantly higher uptake of 99mTc than those in group 2 (P < 0.05). Interestingly, three patients in group 1 were positive for thyroid-stimulating antibodies (TSAbs) (249% +/- 17%; normal < 145%), which were not detected in the remaining eight patients. Antibodies against thyroglobulin and microsomal antigens were detected in nine nine (81.8%) and 11 (100%) patients, respectively, but neither of these titres correlated with the scan image. Three patients in group 1 underwent scintigraphy again after treatment with thyroxine, at which time the functioning lesion was not noted. Fourteen hypothyroid patients with negative TBII displayed no such scintigraphic findings. Chronic stimulation of the thyroid by TSAbs and/or TSH might be responsible for the presence of the functioning lesion, but clarification of the mechanism requires further studies. In summary (1) TSAbs were detected in three (27.3%) of 11 hypothyroid patients with blocking TRAbs; (2) thyroid scintigraphy revealed the presence of localized functioning area(s) in approximately half of these cases.
authors.affiliation: Department of Nuclear Medicine, Kyoto University Hospital, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kasagi
authors.forename: H
authors.initials: H
authors.lastname: Hatabu
authors.forename: S
authors.initials: S
authors.lastname: Miyamoto
authors.forename: R
authors.initials: R
authors.lastname: Takeuchi
authors.forename: T
authors.initials: T
authors.lastname: Misaki
authors.forename: H
authors.initials: H
authors.lastname: Sakahara
authors.forename: Y
authors.initials: Y
authors.lastname: Iida
authors.forename: J
authors.initials: J
authors.lastname: Konishi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001667:Binding, Competitive; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000000981:diagnostic imaging* / Q000276:immunology; D018828:Immunoglobulins, Thyroid-Stimulating / Q000276:immunology*; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D011989:Receptors, Thyrotropin / Q000276:immunology*; D013670:Sodium Pertechnetate Tc 99m; D013961:Thyroid Gland / Q000000981:diagnostic imaging* / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000000981:diagnostic imaging* / Q000276:immunology; D014463:Ultrasonography
chemical_list: D018828:Immunoglobulins, Thyroid-Stimulating; D007457:Iodine Radioisotopes; D011989:Receptors, Thyrotropin; D013670:Sodium Pertechnetate Tc 99m